Impilo Investment Analyst

Impilo – Investing in a healthy future

Impilo is a leading Nordic investment company focused on long-term investments in healthcare companies active in pharmaceuticals, medical technology, healthcare services, and other health-related areas. Operational since 2017, with offices in Stockholm and Copenhagen, Impilo manages c. SEK 10 billion in capital from leading Nordic and international investors. Impilo has been the most active investment firm in Nordic healthcare since inception and currently has a well-diversified portfolio of ten investments in market-leading companies. The companies Impilo invests in shall have a positive health impact, and ESG is an integral part of the investment thesis.